Value of contrast ultrasonography in the detection of significant prostate cancer: Correlation with radical prostatectomy specimens

被引:25
作者
Sedelaar, JPM
van Leenders, GJLH
Goossen, TEB
Hulsbergen-van der Kaa, CA
van Adrichem, NP
Wijkstra, H
de la Rosette, JJMCH
机构
[1] Univ Nijmegen, Dept Urol, Med Ctr St Radboud, UMC Nijmegen, NL-6500 HB Nijmegen, Netherlands
[2] Univ Nijmegen, Dept Pathol, Med Ctr St Radboud, NL-6500 HB Nijmegen, Netherlands
[3] De Eemland Ziekenhuis, Dept Urol, Amersfoort, Netherlands
关键词
contrast ultrasonography; 3D-ultrasonography imaging; prostate cancer; imaging; histology;
D O I
10.1002/pros.10145
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. The presented study has investigated a possible improvement of imaging prostate cancer: three-dimensional contrast-enhanced power Doppler ultrasonography (3D-CE-PDU). METHODS. Seventy patients with biopsy proven prostate cancer and scheduled for radical retropubic prostatectomy received a 3D-CE-PDU investigation before surgery. Two experts analyzed the ultrasound images. The ultrasound images were correlated to the whole-mount sections of the prostate specimen. The correlation protocol consisted of three evaluation steps. RESULTS. In total, 153 prostate tumors were found in the 70 prostate specimens: 61 tumors <5 mm, 93 tumors greater than or equal to5 mm. The diagnosis of clinical significant and insignificant prostate cancer was made in 85 and 88% of the patients for expert I and II, respectively. Diagnosis by imaging improved from 61% (43 of 70 of the prostate cancers) for standard detection tools to an average 86% (60 of 70 prostate cancers) for 3D-CE-PDU. CONCLUSION. 3D-CE-PDU improves the detection of prostate cancer in this group of prostate cancer patients. The use of 3D-CE-PDU in the clinic is questionable as indications are still unclear.
引用
收藏
页码:246 / 253
页数:8
相关论文
共 24 条
[1]  
Blomley MJ, 1997, RADIOLOGY, V205, P598
[2]   Contrast-enhanced three-dimensional power Doppler angiography of the human prostate: Correlation with biopsy outcome [J].
Bogers, HA ;
Sedelaar, JPM ;
Beerlage, HP ;
de la Rosette, JJMCH ;
Debruyne, FMJ ;
Wijkstra, H ;
Aarnink, RG .
UROLOGY, 1999, 54 (01) :97-104
[3]   Twelve prostate biopsies detect significant cancer volumes (&gt; 0.5 mL) [J].
Brössner, C ;
Bayer, G ;
Madersbacher, S ;
Kuber, W ;
Klingler, C ;
Pycha, A .
BJU INTERNATIONAL, 2000, 85 (06) :705-707
[4]   Ultrasonographic contrast media in the urinary tract [J].
Cosgrove, DO ;
Kiely, P ;
Williamson, R ;
Blomley, MJK ;
Eckersley, RJ .
BJU INTERNATIONAL, 2000, 86 :11-17
[5]  
Douglas TH, 1997, PROSTATE, V32, P59
[6]   The definition and preoperative prediction of clinically insignificant prostate cancer [J].
Dugan, JA ;
Bostwick, DG ;
Myers, RP ;
Qian, JQ ;
Bergstralh, EJ ;
Oesterling, JE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (04) :288-294
[7]   Impalpable invisible stage tie prostate cancer: Characteristics and clinical relevance in 100 radical prostatectomy specimens - A different view [J].
Elgamal, AAA ;
VanPoppel, HP ;
VandeVoorde, WM ;
VanDorpe, JA ;
Oyen, RH ;
Baert, LV .
JOURNAL OF UROLOGY, 1997, 157 (01) :244-250
[8]   Nonpalpable stage T1c prostate cancer: Prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings [J].
Epstein, JI ;
Chan, DW ;
Sokoll, LJ ;
Walsh, PC ;
Cox, JL ;
Rittenhouse, H ;
Wolfert, R ;
Carter, HB .
JOURNAL OF UROLOGY, 1998, 160 (06) :2407-2411
[9]   Distinguishing clinically important from unimportant prostate cancers before treatment: Value of systematic biopsies [J].
Goto, Y ;
Ohori, M ;
Arakawa, A ;
Kattan, MW ;
Wheeler, TM ;
Scardino, PT .
JOURNAL OF UROLOGY, 1996, 156 (03) :1059-1063
[10]   Prostate cancer: Contrast-enhanced US for detection [J].
Halpern, EJ ;
Rosenberg, M ;
Gomella, LG .
RADIOLOGY, 2001, 219 (01) :219-225